ClinicalTrials.gg
BiologicalDrug

Keyhole limpet hemocyanin clinical trials

studies test it
12
open now
0
in phase 3
1
first study started
1995

How each study uses keyhole limpet hemocyanin is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

KLH
6
keyhole limpet hemocyanin
5
Immucothel
2
keyhole-limpet hemocyanin
2

Studies by the year they started

12 studies that test it; most in 2011 (2)

Studies that test keyhole limpet hemocyanin, by start year
YearStudies
19951
19981
20001
20011
20031
20071
20081
20112
20121
20191
20231

By phase

A phase 1/2 study counts in both.

Early Phase 1
1
Phase 1
5
Phase 2
4
Phase 3
1
No phase
2

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 3 · Other 9

National Cancer Institute (NCI) (2) · National Institute of Allergy and Infectious Diseases (NIAID) (2) · Ono Pharmaceutical Co. Ltd (1) · Celldex Therapeutics (1) · Intracel (1) · Medical University of Graz (1) · University of Nebraska (1) · Masonic Cancer Center, University of Minnesota (1)

Often tested with

Tested in the same studies.

Sargramostim (2) · Besufetamig (1) · Rindopepimut (1) · Interleukin-4 (1) · Endotoxins (1) · Autologous Tumor Cell Vaccine (1) · Tetanus Toxoid (1) · Granulocyte-Macrophage Colony-Stimulating Factor (1)

Studies

Open first, then newest update. How each study uses keyhole limpet hemocyanin is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 12

Given beside what is tested · 10 — keyhole limpet hemocyanin is usual care or a partner of the new treatment
As the comparator · 1 — what is tested is compared with keyhole limpet hemocyanin

Codes

What other systems call keyhole limpet hemocyanin · ClinicalTrials.gg INT002990

  • MeSH (NLM) C032808keyhole-limpet hemocyaninConfirmed ClinicalTrials.gov, NLM
  • UNII (FDA) FV4Y0JO2CXKEYHOLE LIMPET HEMOCYANINConfirmed FDA, NLM
  • NCI Thesaurus C1139Keyhole Limpet HemocyaninOne source FDA

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.